Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2018 16:32 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
November 08, 2017 16:01 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
November 01, 2017 16:05 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update

SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will...
October 19, 2017 09:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock

SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
September 18, 2017 16:05 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Two Upcoming Conferences

SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
August 09, 2017 16:31 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results

SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
May 10, 2017 17:06 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports First Quarter 2017 Financial Results

SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
March 15, 2017 17:22 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

SAN DIEGO, March 15, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
February 21, 2017 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVC

Further Development of CD101 Topical for VVC to be discontinued CD101 IV development program in candidemia and invasive candidiasis (including Phase 2 STRIVE trial) continuing and remains on track ...
November 10, 2016 16:10 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results

SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right